Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    Menu

    Falcon

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 933Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Skyhawk Therapeutics Reports Positive Phase 1 Results
    Skyhawk Therapeutics Reports Positive Phase 1 Results

    17 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/skyhawk-therapeutics-announces-positive-first-interim-results-in-patients-from-its-phase-1-clinical-trial-of-sky-0515-as-a-treatment-for-huntingtons-disease-302559083.html

    PR NEWSWIRE
    17 Sep 2025
    Share Share
    Alcyone secures funding for pediatric precision Therapeutics
    Alcyone secures funding for pediatric precision Therapeutics

    24 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alcyone-therapeutics-announces-strategic-financing-to-advance-an-expanded-pipeline-of-pediatric-focused-precision-therapeutics-for-severe-neurological-diseases-302436946.html

    PR NEWSWIRE
    24 Apr 2025
    Share Share
    Galapagos reports initiation of FALCON clinical trial in cystic fibrosis
    Galapagos reports initiation of FALCON clinical trial in cystic fibrosis

    24 Apr 2018

    // FINANCE

    https://finance.yahoo.com/news/galapagos-reports-initiation-falcon-clinical-064626530.html

    FINANCE
    24 Apr 2018
    Share Share